-
Founded in:
1996-09-16 -
Country:
China -
Address:
No. 58, Xingang Avenue, Nanjing Economic and Technological Development Zone -
Tax NO.:
9132019270413930XB -
Registered Funds:
- -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 9beta;-D-ribosyl hypoxanthine |
This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body.
More
This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diclofenac sodium |
This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.
More
This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters. |
15307-79-6 | 55 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diclofenac sodium |
This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.
More
This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters. |
15307-79-6 | 55 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Oleanolic acid |
It has a certain protective effect on liver damage, can reduce elevated serum alanine aminotransferase, promote liver cell regeneration, and accelerate the repair of necrotic tissue.
More
It has a certain protective effect on liver damage, can reduce elevated serum alanine aminotransferase, promote liver cell regeneration, and accelerate the repair of necrotic tissue. |
508-02-1 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| APRINDINE HCL |
This product belongs to Class Ib antiarrhythmic drugs, inhibits the permeability of cell membrane to Na, but does not promote K outflow. It can slow down the conduction of various parts of the cardiac conduction system, reduce membrane reactivity, increase the excitation threshold, prolong the effective adaptation period of the atrium, atrioventricular node, His-Purkinje system (Purkinjes fibers) and ventricle, and block the forward and reverse conduction of the bypass pathway.
More
This product belongs to Class Ib antiarrhythmic drugs, inhibits the permeability of cell membrane to Na, but does not promote K outflow. It can slow down the conduction of various parts of the cardiac conduction system, reduce membrane reactivity, increase the excitation threshold, prolong the effective adaptation period of the atrium, atrioventricular node, His-Purkinje system (Purkinjes fibers) and ventricle, and block the forward and reverse conduction of the bypass pathway. |
33237-74-0 | 2 |